Who
Rami Levin
CEO and President
Company insider
Files Form 4 as: CEO and President, CNS Pharmaceuticals.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jan 2026
- Last trade
- 14 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 18 Aug 2026 | CNSP CNS PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —4,750 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,750 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,750 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CNSP CNS PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —4,750 at $0.00 | filing |
| 1 Jan 2026filed 2 Jan 2026 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 | filing |
| 1 Jan 2026filed 2 Jan 2026 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.